Although this effect may be addressing a deficit specific to SCA38, omega-3 treatment has been reported to be broadly beneficial in age-related cognitive decline, in other forms of ataxia and in neurodegenerative disorders (Kerdiles and Calon 2017; Ricca et al. 2020). This evidence concerns the gene ELOVL5 and Ataxia.